Analysts are intrested in these 5 stocks: ( (BYND) ), ( (ATYR) ), ( (VFC) ), ( (WBD) ) and ( (PLD) ). Here is a breakdown of their recent ratings and the rationale behind them.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Beyond Meat has recently faced a downgrade from analyst Taylor Conrad, who shifted the stock rating from Hold to Sell. Despite beating consensus expectations in their 2Q25 results, Beyond Meat’s shares have underperformed significantly, dropping 23% over the past three months. The company is grappling with challenges such as a weak balance sheet, increased competition, and a shift in consumer perception regarding the health benefits of their products. Additionally, the company has faced pressures from rising input costs and lower demand for plant-based proteins, leading to several cost-cutting measures, including layoffs. The analyst suggests that a recovery in demand and improvement in margins could warrant a future upgrade.
aTyr Pharma has also seen a downgrade from analysts Joseph Pantginis and Soumit Roy, both moving the stock to a Hold rating. The downgrade follows the Phase 3 EFZO-FIT trial, which missed its primary endpoint, leading to uncertainty about the company’s path forward. Despite some positive clinical outcomes, the unexpected high placebo response has raised questions about the trial’s design and future prospects. The company plans to engage with the FDA to discuss the next steps, and analysts are waiting for clearer guidance before making further recommendations.
VF Corporation has been downgraded to Hold by analyst Peter Mcgoldrick, following a favorable sale of the Dickies brand for $600 million. While the sale is seen as a positive move to alleviate capital constraints, the overall risk/reward balance appears neutral at this point. The company is focusing on its core brands, such as Vans and The North Face, but challenges remain, particularly with the Vans brand. The analyst notes that while the company has made strides in improving its financial health, further confidence in accelerating fundamentals is needed for a more positive outlook.
Warner Bros. Discovery has been downgraded to Hold by analyst Doug Creutz, amidst speculation of a potential acquisition bid by Paramount Skydance. The stock has surged beyond the analyst’s price target due to the unconfirmed report, but the risk of the bid not materializing poses a significant downside. The analyst highlights the speculative nature of the current rally and the elevated risk profile, suggesting that moving to the sidelines might be the best course of action until more concrete details emerge.
Prologis has received an upgrade to Buy from analyst Samir Khanal, with a new price target of $130. The upgrade follows positive developments in corporate decision-making and a record-high leasing pipeline. The company is expected to convert more pent-up demand into signed leases, despite a challenging macroeconomic environment. Prologis offers a differentiated platform with multiple growth levers, including market rent growth and data center conversions. The analyst believes the downside risks are largely priced in, and the stock’s valuation presents an attractive opportunity for investors.